Grandall Building, No.2＆No.15, Block B, Baita Park, Old Fuxing Road, Hangzhou, Zhejiang 310008, China 国浩律师（杭州）事务所 关于 杭州豪悦护理用品股份有限公司 2024 年年度股东大会 之 法律意见书 地址：杭州市上城区老复兴路白塔公园 B 区 2 号、15 号国浩律师楼 邮编：310008 网址/Website：http://www.grandall.com.cn 二〇二五年五月 国浩律师（杭州）事务所 法律意见书 国浩律师（杭州）事务所 关于杭州豪悦护理用品股份有限公司 2024 年年度股东大会之 法律意见书 致：杭州豪悦护理用品股份有限公司 国浩律师（杭州）事务所（以下简称"本所"）接受杭州豪悦护理用品股份 有限公司（以下简称"公司"）委托，指派律师出席公司 2024 年年度股东大会（以 下简称"本次股东大会"），并依据《中华人民共和国公司法》（以下简称《公司 法》）、《中华人民共和国证券法》（以下简称《证券法》）、中国证券监督管理委员 会（以下简称"中国证监会"）发布的《上市公司股东会规则》（以下简 ...

Investment Rating - The investment rating for the company is "Buy-A" with a target price of 61.06 CNY, maintaining the rating [5][12]. Core Views - The company reported a revenue of 2.929 billion CNY for 2024, a year-on-year increase of 6.25%, while the net profit attributable to shareholders was 388 million CNY, a decrease of 11.65% [1]. - The acquisition of Hubei Sibao is expected to enhance the brand value and market share of the company's products, particularly the "Jieting" brand [3]. - The company is focusing on expanding its overseas market presence, particularly in Thailand, through a multi-channel strategy [3]. Financial Performance - In 2024, the company achieved revenues of 2.060 billion CNY from baby hygiene products, 0.552 billion CNY from adult hygiene products, and 0.232 billion CNY from other products, with respective year-on-year growth rates of 4.3%, -0.5%, and 57.6% [2]. - The gross margin for 2024 was 27.91%, an increase of 0.97 percentage points year-on-year, while the net margin was 13.23%, a decrease of 2.68 percentage points [11]. - The company expects revenues to grow to 3.921 billion CNY in 2025, representing a year-on-year growth of 33.84% [12]. Market Strategy - The company plans to leverage its production bases across China to enhance production efficiency and reduce logistics costs [3]. - The strategy includes deepening the local market presence in Thailand and expanding into surrounding countries [3]. Future Projections - The projected net profit for 2025 is 496 million CNY, with a year-on-year growth of 27.95% [12]. - The company anticipates a steady increase in revenue and profit over the next few years, with expected revenues of 4.392 billion CNY in 2026 and 4.969 billion CNY in 2027 [12].

证券时报·数据宝统计，截至上午收盘，今日沪指跌0.08%，A股成交量624.22亿股，成交金额7282.14亿 元，比上一个交易日增加11.32%。个股方面，3883只个股上涨，其中涨停72只，1340只个股下跌，其 中跌停33只。从申万行业来看，计算机、美容护理、传媒等涨幅最大，涨幅分别为2.38%、2.00%、 1.55%；银行、钢铁、公用事业等跌幅最大，跌幅分别为2.76%、0.65%、0.48%。（数据宝） 今日各行业表现（截至上午收盘） | 申万行业 | 行业涨跌（%） | 成交额（亿元） | 比上日（%） | 领涨（跌）股 | 涨跌幅（%） | | --- | --- | --- | --- | --- | --- | | 计算机 | 2.38 | 852.58 | 35.16 | 创意信息 | 19.93 | | 美容护理 | 2.00 | 51.80 | 11.82 | 豪悦护理 | 8.77 | | 传媒 | 1.55 | 220.77 | 13.70 | 浙文互联 | 10.01 | | 电子 | 1.46 | 911.91 | 28.69 | 光大同创 | 17.45 | | 汽车 | ...

杭州豪悦护理用品股份有限公司 会议资料 2024 年年度股东大会 2025 年 5 月 12 日 杭州豪悦护理用品股份有限公司 2024 年年度股东大会 2024 年年度股东大会会议须知 为维护广大投资者的合法权益，保障股东在本次股东大会期间依法行使权利， 根据《公司法》、中国证监会《上市公司股东大会规则》和公司《股东大会议事 规则》等有关规定，特制定本会议须知： 一、公司负责本次股东大会的议程安排和会务工作，出席会议人员应当听从 公司工作人员安排，共同维护好会议秩序。 二、为保证股东大会的正常秩序，除出席会议的股东或者股东代理人、董事、 监事、高级管理人员、见证律师及董事会邀请的人员外，公司有权依法拒绝其他 人员进入会场。 三、出席会议的股东须在会议召开前 15 分钟到达会议现场向公司会务人员 办理签到手续，并请按规定出示股票账户卡、持股凭证、身份证或法人单位证明、 授权委托书及出席人身份证等，经验证后领取会议资料，方可出席会议。 四、股东需要在股东大会发言的，应于会议开始前 15 分钟向公司会务人员 进行登记，出示有效的持股证明，填写《发言登记表》；登记发言的人数原则上 以十人为限，超过十人时安排持股数最 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [7] Core Insights - The company's revenue for Q1 2025 reached 910 million yuan, representing a year-on-year increase of 42.4%, with a net profit attributable to shareholders of 91 million yuan, up 5.7% year-on-year. The growth is driven by the consolidation of the "Jieting" brand and a recovery in the core diaper business [1][2] - The acquisition of Hubei Sibao Care, completed on January 20, 2025, significantly contributed to revenue growth, with the "Jieting" brand showing strong performance on e-commerce platforms [2] - The gross margin improved significantly to 34.67%, up 6.96 percentage points year-on-year, primarily due to the higher gross margin from the Sibao brand compared to the company's traditional OEM business [3] - The company is expanding its production capacity despite market challenges, enhancing its market share and positioning for long-term growth through its own brands [4] - The company is expected to maintain a high dividend payout ratio of approximately 67% in 2024, with projected revenues of 3.744 billion yuan in 2025, reflecting a year-on-year growth of 27.83% [5] Summary by Sections Financial Performance - In Q1 2025, the company achieved a gross margin of 34.67%, a year-on-year increase of 6.96 percentage points, while the net profit margin decreased to 9.95%, down 3.96 percentage points year-on-year due to increased sales expenses and a decline in interest income [3] - Revenue projections for 2025-2027 are 3.744 billion, 4.203 billion, and 4.664 billion yuan, with corresponding year-on-year growth rates of 27.83%, 12.26%, and 10.95% [5][12] Market Position and Growth Potential - The company is expanding its production capacity through acquisitions and is expected to see significant growth in its own brands, particularly in the Thai market [4] - The "Jieting" brand's performance on e-commerce platforms indicates strong market demand, contributing to the overall revenue growth [2]

证券代码：605009 证券简称：豪悦护理 公告编号：2025-026 杭州豪悦护理用品股份有限公司 关于2024年年度股东大会增加临时提案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 股东大会有关情况 1. 股东大会的类型和届次： 2024年年度股东大会 | 股份类别 | 股票代码 | 股票简称 | 股权登记日 | | --- | --- | --- | --- | | Ａ股 | 605009 | 豪悦护理 | 2025/5/6 | 二、 增加临时提案的情况说明 公司已于2025 年 4 月 15 日公告了股东大会召开通知，单独或者合计持有 34.73%股份的股东李志彪，在2025 年 4 月 25 日提出临时提案并书面提交股东 2. 股东大会召开日期：2025 年 5 月 12 日 3. 股权登记日 1. 提案人：李志彪 2. 提案程序说明 大会召集人。股东大会召集人按照《上市公司股东大会规则》有关规定，现予以 公告。 3. 临时提案的具体内容 李志彪先生于 2025 年 4 月 25 日向本公司提出《关于 ...

证券代码：605009 证券简称：豪悦护理 公告编号：2025-025 杭州豪悦护理用品股份有限公司 第三届监事会第十一次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 杭州豪悦护理用品股份有限公司(以下简称"公司")第三届监事会第十一次 会议于 2025 年 4 月 25 日以现场结合通讯的方式召开。会议通知已于 2025 年 4 月 19 日通过邮件的方式送达全体监事。会议应出席监事 3 人，实际出席会议的 监事 3 人，监事会主席陈昶先生主持本次会议。本次监事会会议的召集、召开和 表决程序符合有关法律、行政法规、部门规章、规范性文件和《公司章程》的规 定。 二、监事会会议审议情况 本次监事会会议形成如下决议: (一)审议通过《2025 年一季度报告》 表决结果:3 票同意，0 票反对，0 票弃权。 (二)审议通过《关于注销部分回购股份的议案》 具体内容详见公司同日在上海证券交易所网站(www.sse.com.cn)披露的《杭 州豪悦护理用品股份有限公司关于注销部分回购股份的公告》 表 ...

证券代码：605009 证券简称：豪悦护理 公告编号：2025-028 杭州豪悦护理用品股份有限公司 第三届董事会第十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 杭州豪悦护理用品股份有限公司(以下简称"公司")第三届董事会第十五次 会议于 2025 年 4 月 25 日以现场结合通讯的方式召开。会议通知已于 2025 年 4 月 19 日通过邮件的方式送达全体董事。会议应出席董事 7 人，实际出席会议的 董事 7 人，董事长李志彪先生主持本次会议。本次董事会会议的召集、召开和表 决程序符合有关法律、行政法规、部门规章、规范性文件和《公司章程》的规定。 具体内容详见公司同日在上海证券交易所网站(www.sse.com.cn)披露的《杭 州豪悦护理用品股份有限公司 2025 年第一季度报告》 表决结果:同意 7 票，反对 0 票，弃权 0 票。 (二)审议通过《关于注销部分回购股份的议案》 该议案尚需提交股东大会审议。 具体详见公司同日在上海证券交易所网站（www.sse.com.cn ...

证券代码：605009 证券简称：豪悦护理 公告编号：2025-027 杭州豪悦护理用品股份有限公司 关于注销部分回购股份的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 杭州豪悦护理用品股份有限公司(以下简称"公司")于 2025 年 4 月 25 日召 开第三届董事会第十五次会议，审议通过了《关于注销部分回购股份的议案》， 同意公司注销回购股份 421,865 股，该事项尚需提交股东大会审议。现将相关情 况公告如下： 一、股份回购情况概述 1、公司分别于 2021 年 10 月 13 日召开的第二届董事会第九次会议，于 2021 年 10 月 29 日召开 2021 年第三次临时股东大会，均审议通过了《杭州豪悦护理 用品股份有限公司关于以集中竞价交易方式回购公司股份方案的议案》（以下简 称《回购方案》），同意公司通过自有资金以集中竞价交易方式回购公司股份，回 购资金总额不低于人民币 14,000 万元（含），不超过人民币 20,000 万元（含）， 回购股份价格不超过人民币 75.00 元/股，回购期限自公司股东大会 ...

Financial Performance - The company's operating revenue for Q1 2025 reached ¥911,071,132.46, representing a 42.42% increase compared to ¥639,711,881.28 in the same period last year[4] - Net profit attributable to shareholders was ¥90,611,325.29, a 5.67% increase from ¥85,748,400.75 year-on-year[4] - Total operating revenue for Q1 2025 reached ¥911,071,132.46, a 42.4% increase from ¥639,711,881.28 in Q1 2024[21] - Net profit for Q1 2025 was ¥90,611,325.29, representing a 5.0% increase compared to ¥85,748,400.75 in Q1 2024[22] - Earnings per share for Q1 2025 was ¥0.59, compared to ¥0.55 in Q1 2024[22] Cash Flow - The net cash flow from operating activities improved significantly to ¥40,390,306.75, compared to a negative cash flow of ¥94,242,746.79 in the previous year, marking a 142.86% change[4] - Cash flow from operating activities for Q1 2025 was ¥40,390,306.75, a significant improvement from a negative cash flow of ¥94,242,746.79 in Q1 2024[24] - The company reported a total cash outflow from operating activities of ¥823,737,609.95 in Q1 2025, compared to ¥597,338,449.33 in Q1 2024[24] - The net cash flow from investing activities was -196,359,818.84, compared to -102,673,180.86 in the previous period, indicating a significant increase in cash outflow for investments[25] - The net cash flow from financing activities was 24,051,598.14, a recovery from a negative cash flow of -88,084,003.45 in the previous period[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,173,400,418.40, up 6.63% from ¥4,851,759,098.61 at the end of the previous year[5] - Total liabilities as of the end of the reporting period were ¥1,780,381,038.94, up from ¥1,550,622,539.98 in the previous period[18] - The total liabilities decreased from ¥1,373,000,000 to ¥1,200,000,000, indicating a reduction of approximately 12.6%[16] - The total equity attributable to shareholders was ¥3,393,019,379.46, an increase from ¥3,301,136,558.63 in the previous period[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,893[10] - The top three shareholders hold a combined total of 96,984,141 shares, representing 62.78% of the total shares[10] - The company has no pledged, marked, or frozen shares among the top shareholders[10] Research and Development - The company reported a 49.05% increase in R&D expenses, indicating a focus on enhancing product development[9] Acquisitions and Market Expansion - The company completed the acquisition of Hubei Sibao Hygiene Products Co., Ltd., which is now a wholly-owned subsidiary[14] - The company plans to continue expanding its market presence, particularly through the integration of Hubei Sibao into its operations[9] Inventory and Receivables - Accounts receivable rose by 148.90%, primarily due to increased customer receivables and the consolidation of Hubei Sibao[8] - Inventory rose from ¥320,919,462.61 to ¥393,824,431.15, marking an increase of approximately 22.6%[16] - Accounts receivable increased significantly from ¥136,843,080.41 to ¥340,597,759.20, reflecting a growth of about 148.5%[16] Expenses - The company experienced a 182.96% increase in selling expenses, attributed to the consolidation of Hubei Sibao and increased sales activities[9] - Total operating costs for Q1 2025 were ¥800,306,829.41, up 48.5% from ¥539,179,011.57 in Q1 2024[21] Cash Management - The company's cash and cash equivalents decreased from ¥1,382,527,655.60 to ¥1,250,598,175.32, a decline of approximately 9.5%[16] - The total cash and cash equivalents at the end of the period decreased to 1,250,598,175.32 from 2,007,274,917.96, showing a decline of approximately 37.5%[25] - The cash flow from operating activities was not detailed, but the overall cash and cash equivalents net decrease was -131,929,480.28, compared to -284,353,110.32 in the previous period, suggesting improved cash management[25] Debt Management - The company’s cash outflow for repaying debts was 199,000,000.00, slightly higher than the previous period's 190,000,000.00, indicating ongoing debt management efforts[25]